I never doubted carepls, but in the short-term it is wise for members to consider a hedge to cushion against turbulence.

duopharma is now a penny stock. overpriced with very low yields, low profits to show. it has proven over the last 2 months unable to breach more than 3.50. it will stay at this range. dead...no point buying. buy the cheaper ones can make more money % yield is higher as you can see market is smart. volume is high for stocks like solution. solid and steady...on a strong upward trend. 1 ringgit is the market target.

duopharma and pharmaniaga are not attractive because they are overpriced. and they have not mentioned which corona virus vaccine they are getting. all speculation about them. and the yield is very little. no point buying that stocks

stock on a massive uptrend...

https://disclosure.bursamalaysia.com/FileAccess/apbursaweb/download?id=106130&name=EA_GA_ATTACHMENTS

This is just a hedge I am still a believer in gloves... my personal opinion just to cushion any short-term impact of another massive panic sell.

Solution Berhad has one of the best prospects as its vaccine candidate is currently the leading one that may probably be approved. It has incorporated a specialised subsidiary Solution Biologics Sdn Bhd. to partner with Cansino.

CanSino Biologics, a Chinese vaccine maker has announced several sets of positive trial results, is already providing a vaccine to People’s Liberation Army soldiers. CanSino’s Ad5-nCoV candidate has long been China’s leading COVID-19 vaccine candidate, after it became the first in the world to begin clinical trials on March 16. The company conducted Phase I and II trials in Wuhan, China, and published the results of the trials in The Lancet medical journal.

In mid-May, CanSino also announced a partnership with the National Research Council of Canada and got the green light to begin clinical trials with Canadian patients. The trials are being conducted over a six-month period in partnership with researchers at Dalhousie University in Halifax, Nova Scotia.

https://www.cnbc.com/2020/06/29/cansinos-coronavirus-vaccine-candidate...

candidates:

1. Solution Bhd- uptrend
2. Bintai Kidden

both are sufficiently low for a hedge ...

buy the low ones if you want to hedge ...not the overpriced ones as you will not earn much...

carepls is currently on a downtrend due to lack of catalysts. Either buy more to lower holding costs or take a hedge ... this is not a buy or sell call just a food for thought...

at this volatile environment, I think taking a hedge is a good strategy... to cushion any impact...

pharma stocks are a good hedge if you buy low. e.g. Solution Berhad signed a very promising MOU with cansino vaccine, the leading china vaccine candidate approved for their Chinese PLA military use. They even incorporated a specialised subsidiary to undertake the vaccine commercialisation scheduled to be in Nov. It is a good hedge just in case the massacre happened again like the 1-2 weeks back.

good opportunity to collect now. remember to buy low sell high later...

limitup@ unlike your barbaric ways, these news is not a buy or sell call... beware asking people to buy or sell - this is an offence under the Securities laws in Malaysia. You have no class at all. people like you only know how to shout and make noise. totally no facts. you based your decisions on pure luck and sentiments.

https://fortune.com/2020/06/29/china-coronavirus-vaccine-military/

CanSino Biologics, a Chinese vaccine maker has announced several sets of positive trial results, is already providing a vaccine to People’s Liberation Army soldiers. CanSino’s Ad5-nCoV candidate has long been China’s leading COVID-19 vaccine candidate, after it became the first in the world to begin clinical trials on March 16. The company conducted Phase I and II trials in Wuhan, China, and published the results of the trials in The Lancet medical journal.

In mid-May, CanSino also announced a partnership with the National Research Council of Canada and got the green light to begin clinical trials with Canadian patients. The trials are being conducted over a six-month period in partnership with researchers at Dalhousie University in Halifax, Nova Scotia.

Of all the vaccines out there, cansino's vaccine is the most highly regarded vaccine candidate as it is currently undergoing late trials testing alongside Moderna's candidate vaccine from the US.

https://www.ft.com/content/2c3ae017-6c09-4f7e-93b8-f8039fe79a6c

https://www.cnbc.com/2020/06/29/cansinos-coronavirus-vaccine-candidate-approved-for-military-use-in-china.html

Solution Biologics Sdn Bhd has just been incorporated as a specialised subsidiary to undertake the vaccine commercialiation process in Malaysia. This has been announced in Bursa. Of all the companies out there like Titijaya and Bintai, this is the most authentic.

The number of new cases of coronavirus rose by almost 260,000 in 24 hours - the largest single-day increase since the pandemic began, the World Health Organization (WHO) said on Saturday.

According to the WHO, this is the first time the number of new daily infections has surpassed a quarter of a million.

The biggest increases were in the US, Brazil, India and South Africa.

more covid outbreaks in Europe- with the flu season fast approaching during winter, more coronavirus cases will occur and this is when gloves will rise to the highest...

https://www.nytimes.com/2020/08/21/world/europe/coronavirus-second-wave.html

The director has disposed off his warrants meaning he also does not think the current price is making sense. Exercise caution. this remains a penny stock which is a loss making company.

limitup@ is clearly someone who wants to make a quick buck out of the masses here. very desperate to ask people to buy high so he can sell off his share and pocket the quick money. Never accumulate this stock above 50 cents at this moment. it is not worth that much. the first round of limit up has already factored in the premium of the upcoming MOU. we need more concrete news and positive facts e.g. profit projections in order buy higher. Remember having a business venture in the future is not necessarily profit making. To think otherwise is to speculate...no point comparing with gloves. PROFIT for gloves is a fact now for the upcoming quarters.

like i said, this is a loss making company unlike gloves. never buy above 50 cents. Solution has never been making money for awhile. No fundamentals at all unlike carepls adventa etc. Their profits are not even guaranteed. Never count your chickens before they hatch. before profits lock in you buy high make it over price. what are you going to earn?

another joker is the pharma...vaccine not yet release. people already accumulate and make it over-price. really mad...and then just speculate on their profits which may not even be realised. people are really illogical

exactly. glove profits will keep on increasing until next year so why worry. sometimes i red the comments, I laugh. you want to buy airline stocks now when they are making losses? glove making big profits don't want to buy, go and panic sell. really crazy people

tomorrow it drops will surely buy again ...

so buy carepls while it is still trading low

carepls stands the best chance in terms of % yield upside ...

many people seem to think top glove can hit higher after bonus issue, think again...it is a share split not FREE SHARES... after bonus issue there will be a billion more shares...to even move 30 cents you need a huge volume. much easier to move a stock like carepls which is trading at an attractively and relatively low PE ratio...

the TP is 9.0 it has never changed

unlike gloves, this is a penny stock ...

best to buy below 50 cents. never buy above it. otherwise, you cannot make. and the price is not stable it drops

but never buy above 50 cents if you want to make profit...

and by the way, GLCs only control government contracts...private hospitals can still use foreign vaccines if they are certified to be safe. so all those people saying only GLCs that is not true. Pharmaniaga and Duopharma only control government contracts.

if you want fundamentals. buy glove stock simple...profits locked in for the next year...nothing can be better than that...

Ho Wah Genting berhad is a good example it is a loss making company but look at its share price now. 1 ringgit plus eh now...say what you want but it is selling 1 ringgit plus. talk all you want so what no fundamentals. people are buying into the future the dream

no body cares la dude about your calculations. this is a goreng stock what you expect? vaccine to change fortunes. got to use brains. you want fundamentals buy glove...

communist story where can believe...at one point they lie to the world about the virus, now they say vaccine found. crazy stories

https://www.theedgemarkets.com/article/india-marks-grim-covid19-milestone-three-million-infections

safer choice is a GLOVE STOCK

director disposing warrants not a good sign ...this is a penny stock. will drop spectacularly

upcoming catalysts for Sept full blown rally no.3 of 2020:

1. BNM rate cuts causing liquidity to pump into glove stocks due to the exponential profit growths.
2. TG bonus issues and dividends lifting glove
3. WINTER SEASON MORE FLU MORE CORONA CASES
4. possibly more mutation strains coming up due to the cold winter season. vaccine development facing roadblocks

this is just the beginning of the glove rally no.3

Us export ban should lift very soon and all the good news will come in September

1. winter season starts in Europe = more coronavirus
2. BNM cut interest rates.
3. bonus issue
4. more dividends payments
5. Q2 results announced - forecasted to be exceeding 1 billion in revenue best ever but not the best yet with more ASP hikes announced for septermber

I should think top glove will hit 36 before bonus issue. With Tan Sri declaring his intention to buy more shares during closed period, this thing has a very bright future. once bonus issue happens this thing will shoot up like a rocket.

bunch of liars out there want to gain political mileage...

these bunch of vaccine manufacturers, so arrogant, have not even started phase 3 trials - only enrolment now, talk as if their chicken have hatched. So arrogant,...all cutting corners. unsafe products endangering lives...